Cargando…
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group
Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic cell transplantation (HCT) is associated with systemic inflammation and endothelial dysfunction, increasing risk for thromboembolic events (TEE). In 145 adult recipients who developed cGVHD after a matched sibling or umbilical...
Autores principales: | El Jurdi, Najla, Elhusseini, Heba, Beckman, Joan, DeFor, Todd E., Okoev, Grigori, Rogosheske, John, Lazaryan, Aleksandr, Weiler, Kristen, Bachanova, Veronika, Betts, Brian C., Blazar, Bruce R., Brunstein, Claudio G., He, Fiona, Holtan, Shernan G., Janakiram, Murali, Gangaraju, Radhika, Maakaron, Joseph, MacMillan, Margaret L., Rashidi, Armin, Warlick, Erica D., Bhatia, Smita, Vercellotti, Gregory, Weisdorf, Daniel J., Arora, Mukta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131386/ https://www.ncbi.nlm.nih.gov/pubmed/34006823 http://dx.doi.org/10.1038/s41408-021-00488-2 |
Ejemplares similares
-
Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
por: Herzog, Shannon, et al.
Publicado: (2023) -
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
por: Holtan, Shernan G., et al.
Publicado: (2023) -
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate
por: El Jurdi, Najla, et al.
Publicado: (2023) -
Higher Therapeutic Cyclosporine Levels Early Post-Transplantation Reduces Risks of Acute Graft-Versus-Host Disease and Improves Survival
por: Rogosheske, John R., et al.
Publicado: (2013) -
Temporal variation in oral microbiome composition of patients undergoing autologous hematopoietic cell transplantation with keratinocyte growth factor
por: Bohn, Bruno, et al.
Publicado: (2023)